Merck applies for approval of its new insomnia drug suvorexant

Download PDF Copy

By Dr. Ananya Mandal, MDFeb 7 2012

Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.

According to company sources late-stage studies of the effectiveness of the drug are complete and said it will seek approval from the Food and Drug Administration. Suvorexant is designed to treat insomnia without causing sleepiness the following morning.

“Suvorexant selectively targets an important pathway involved in helping to promote sleep and, if approved, will be a new, first-in-class treatment for patients with insomnia,” said Peter S. Kim, president of Merck Research Laboratories. Suvorexant is one of the five major U.S. filings Merck anticipates for 2012 and 2013.

Posted in: Pharmaceutical News

Tags: Food, Insomnia, Research, Sleep, Sleep Disorder

Comments (0)

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Download PDF Copy

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Mandal, Ananya. (2018, August 23). Merck applies for approval of its new insomnia drug suvorexant. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20120207/Merck-applies-for-approval-of-its-new-insomnia-drug-suvorexant.aspx.
MLA
Mandal, Ananya. "Merck applies for approval of its new insomnia drug suvorexant". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20120207/Merck-applies-for-approval-of-its-new-insomnia-drug-suvorexant.aspx>.
Chicago
Mandal, Ananya. "Merck applies for approval of its new insomnia drug suvorexant". News-Medical. https://www.news-medical.net/news/20120207/Merck-applies-for-approval-of-its-new-insomnia-drug-suvorexant.aspx. (accessed April 27, 2024).
Harvard
Mandal, Ananya. 2018. Merck applies for approval of its new insomnia drug suvorexant. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20120207/Merck-applies-for-approval-of-its-new-insomnia-drug-suvorexant.aspx.